Pre-made Zimbirelimab benchmark antibody (Whole mAb, anti-PDCD1/PD-1 therapeutic antibody, Anti-CD279/PD1/SLEB2/hSLE1 Antibody) for drug discovery and mechanism of action (MOA) research

Cat No.: GMP-Bios-INN-1058

Anti-PDCD1/PD-1 therapeutic antibody (Pre-made Zimbirelimab biosimilar, Whole mAb) is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.



Order information


* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

Catalog No. Package Price(In USD) Qty (Quantity) Sum(In USD)
GMP-Bios-INN-1058-1mg 1mg 3090
GMP-Bios-INN-1058-10mg 10mg Inquiry
GMP-Bios-INN-1058-100mg 100mg Inquiry
GMP-Bios-INN-1058-xmg ≥100mg Inquiry
Shipping Cost: 760.00
Total:

For more than 100mg, click here for inquiry. >>


Description

Products Name (INN Index) Pre-Made Zimbirelimab Biosimilar, Whole Mab, Anti-PDCD1/PD-1 Antibody: Anti-CD279/PD1/SLEB2/hSLE1 therapeutic antibody
INN Name Zimbirelimab
TargetPDCD1/PD-1
FormatWhole mAb
Derivationhuman
Species Reactivityhuman
CH1 IsotypeIgG4 - lambda
VD LCIgG4 - lambda
Highest_Clin_Trial (Jan '20)
Est. Status
100% SI Structure
99% SI Structure
95-98% SI Structure
Year Proposed
Year Recommended
CompaniesArcus Biosciences, Inc. (Hayward CA USA)
Conditions Approved
Conditions Active
Conditions Discontinued
Development TechOmniRat (Open Monoclonal Technology Inc (OMT))